Cingulate, Inc. (CING)
4.95
-0.32
(-6.07%)
USD |
NASDAQ |
May 11, 16:00
5.04
+0.09
(+1.82%)
After-Hours: 20:00
Cingulate EPS Diluted (Quarterly) : -0.8652 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | -0.2988 |
| Assertio Holdings, Inc. | -2.931 |
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -6.273M |
| Total Expenses (Quarterly) | 6.273M |
| Enterprise Value | 59.12M |
| Earnings Yield | -87.89% |
| Normalized Earnings Yield | -85.82 |